Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Boskabady (Mashhad, Islamic Republic of Iran). Anti-inflammatory, antioxidant and immunomodulatory effects of curcumin in sensitized rat. 1052

Member's Comments

No comment yet.

Related content which might interest you: Ovalbumin-induced asthma model in Brown Norway rats demonstrates potential anti-asthmatic effects of Neu-164, a novel antioxidant and anti-inflammatory compound Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008 Anti-oxidative and anti-inflammatory effects of Xanthorrhizol on aeroallergens-induced biological responses in vitro and ex vivo Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity in vivo and inhibits 5-LO and PDE4 Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research Year: 2008 Anti-inflammatory treatment Source: International Congress 2017 – PG3 Bronchiectasis Year: 2017 Anti-inflammatory and anti-oxidative activity of YPL-001 in human bronchial epithelial cells Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017 Enhanced endothelial barrier protective and anti-inflammatory effects by synthetic iloprost-conjugated phospholipid. Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels Year: 2018 Anti-inflammatory properties of synthetic and endogenous Rev-Erb-alpha agonists. Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 The effect of d-limonene as an antioxidant in asthmatic mice model Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 The dietary antioxidant quercetin boosts pulmonary antioxidant defenses Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Neu-164, a novel antioxidant and anti-inflammatory compound, reduces cigarette smoke-induced lung inflammation Source: Annual Congress 2008 - COPD Year: 2008 The anti-inflammatory effects of eucalyptol in a mouse model of LPS-induced pulmonary inflammation are mediated by TRPM8 Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Comparison of in-vitro anti-fibrotic effects of pirfenidone and nintedanib Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 In vitro pharmacological profile of SMP-028, a novel potent anti-inflammatory agent Source: Annual Congress 2010 - Models of airways disease Year: 2010 Novel anti-inflammatory agents Source: Annual Congress 2009 - Emerging trends in the therapy of COPD Year: 2009 Pharmacological induction of A20: Anti-inflammatory effects in paediatric asthma Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 Anti-inflammatory activity of doxofylline and theophylline in LPS-induced lung inflammation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Mechanisms of vascular endothelial cell injury in response to intermittent and continuous hypoxia exposure and protective effects of anti-inflammatory and anti-oxidant agents Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019